title: Anticardiolipin antibodies in hemodialysis patients.
authors.affiliation: Department of Nephrology, Baskent University School of Medicine, Ankara, Turkey.
authors.forename: N
authors.initials: N
authors.lastname: Ozdemir
authors.forename: G
authors.initials: G
authors.lastname: Güz
authors.forename: S
authors.initials: S
authors.lastname: Sezer
authors.forename: A
authors.initials: A
authors.lastname: Haberal
authors.forename: H
authors.initials: H
authors.lastname: Ayaz
authors.forename: M
authors.initials: M
authors.lastname: Haberal
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000097:blood*; D005260:Female; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007676:Kidney Failure, Chronic / Q000276:immunology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects; D013927:Thrombosis / Q000453:epidemiology
chemical_list: D017153:Antibodies, Anticardiolipin; D018937:Hepatitis C Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M